I-Klebsiella Pneumoniae (KPN), i-Acinetobacter Baumannii (Aba)kunye nePseudomonas Aeruginosa (PA) ziintsholongwane eziqhelekileyo ezikhokelela kwizifo ezifunyenwe esibhedlele, ezinokubangela iingxaki ezinkulu ngenxa yokunganyamezelani kwazo namayeza amaninzi, kwanokungamelani ne-last line-antibiotics-carbapenems.
Ngokweendaba zeSifo esiQhambukayo ze-#WHO, the ukwanda kokuchongwai-hypervirulent Klebsiella pneumoniae (hvKp) uhlobo lolandelelwano (ST) 23(hvKp ST23), nto leyoi-carriiiijini ezimelana neentsholongwane ze-carbapenem – iijini ze-carbapenem, kuxelwe ubuncinane1ilizwe elisekonke6Iingingqi ze-WHOUkuvela kwezi ntsholongwane zichasene nee-antibiotics zokugqibela-ii-carbapenemsifuna ukuchongwa kwangethuba nangokuthembekileyo ukuze kube lulaunyango oluchasene neentsholongwane.
Ikhonkco: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON527
I-Klebsiella Pneumoniae,I-Acinetobacter Baumannii kunye nePseudomonas Aeruginosa kunye neDrug Resistance Genes (KPC, NDM, OXA48 kunye ne-IMP) Multiplex ukusuka kwiMacro & Micro-Test, ayichongi nje kuphela i-KPN, i-Aba kunye ne-PA, kodwa ikwachonga ne-4 carbapenemase genes, ezithi kuvavanyo olunye, zinike amandla ulawulo lweklinikhi olufanelekileyo nolufanelekileyo ngexesha elifanelekileyo.
- Uvakalelo oluphezulu lwe-1000 CFU/mL;
- Ikhithi ye-Multiplexi-streamlines ukufunyanwa ukuze kuphetshweokungafunekiyo iimvavanyo;
- Ihambelana kakhulu neenkqubo zePCR eziqhelekileyo;
| I-KPN | Aba | PA | I-KPC | I-NDM | I-OXA48 | I-IMP | |
| I-PPA | 100% | 100% | 98.28% | 100% | 100% | 100% | 100% |
| I-NPA | 97.56% | 98.57% | 97.93% | 97.66% | 97.79% | 99.42% | 98.84% |
| I-OPA | 98.52% | 99.01% | 98.03% | 98.52% | 98.52% | 99.51% | 99.01% |
Ixesha leposi: Agasti-15-2024